Search
Welcome
  • Login
  • Register
Forgot Password?
Lost your password? Please enter your username or email address. You will receive a link to create a new password via email.
Not a subscriber? Subscribe here
Register Now
  • Login
  • Register
Forgot Password?
Lost your password? Please enter your username or email address. You will receive a link to create a new password via email.
                       
Careers & Tenders
Newsletters
Subscribe
The Mail & Guardian
      SUBSCRIBE / Support independent journalism                   CAREERS & TENDERS / Visit careers.mg.co.za                   WHATSAPP? / Follow the M&G WhatsApp channel here            
Login / Register

LOGIN

  • News
    • Africa
    • Business
    • Editorial
    • Education
    • Health
    • Motoring
    • National
    • Sci-tech
    • Sport
    • World
  • Thought Leader
  • Politics
  • Green Guardian
  • Friday
  • Features
    • Buthelezi, the King’s Hand
    • Cabinet Report Cards 2023
    • Cabinet Report Cards 2012-2021
    • The Fiscal Cliff
  • Research World
    • Submissions
    • Papers
  • 200 Young South Africans
  • Events
    • 200 Young South Africans
    • Greening The Future
    • Power Of Women
      • 2024 Edition
    • Critical Thinking Forum
    • Youth Summit
    • Webinars
  • More..
    • Partners
    • Podcasts
    • Crossword
    • Digital Editions
    • Register
    • WhatsApp Channel
    • Login
    • Lost Password

           

Antiretroviral Drugs

Not easy to track how well South Africa is doing with getting people on to ARVs
Article
/ 23 July 2024

Not easy to track how well South Africa is doing with getting people on to ARVs

The world has 18 months left to reach targets that all United Nations member countries signed up to in 2021

By Linda Pretorius, Mia Malan and Media Hack
The renal revolutionary
Partner Content
/ 12 July 2024

The renal revolutionary

From silent killer to centre stage,
Dr June Fabian is spotlighting kidney disease in Africa

By Jamaine Krige
Risks & benefits: new HIV drug combo could change the course of SA’s epidemic
Health
/ 6 December 2019

Risks & benefits: new HIV drug combo could change the course of SA’s epidemic

South Africa’s next chapter in HIV treatment holds amazing promise, but unlocking it rests on having the right kind of discussions with women

By Laura López González
The quest for the (vaginal) ring
Article
/ 19 July 2019

The quest for the (vaginal) ring

The HIV prevention tablet is now available in South Africa but popping a pill every day to stay HIV-negative may not be for everyone

By Roxy de Villiers and Bhekisisa Team
Mark Heywood: ‘I was pitched against the very government I had fought for’
Podcasts
/ 15 July 2017

Mark Heywood: ‘I was pitched against the very government I had fought for’

Activists litigated to force government to give HIV-positive people antiretrovirals. Mia Malan talks to Mark Heywood about the political consequences

By Mia Malan
Exposed: Southern African trio ‘sold expired ARVs’ in Europe at a 4 000% markup
Article
/ 11 November 2016

Exposed: Southern African trio ‘sold expired ARVs’ in Europe at a 4 000% markup

Life-saving HIV drugs were allegedly diverted from Africa’s public health system to sell in Europe.

By Lionel Faull
#AIDS2016: Five things African journalists want to know from Bill Gates
Article
/ 21 July 2016

#AIDS2016: Five things African journalists want to know from Bill Gates

Bill Gates was at the International Aids Conference this week. He spent time with five African journalists. Here is what they wanted to know.

By Ina Skosana
#AIDS2016: From medical circumcision to vaccines, these seven things will change HIV
Article
/ 18 July 2016

#AIDS2016: From medical circumcision to vaccines, these seven things will change HIV

We know more than ever about how to prevent HIV infection, including what may someday lead to the world’s first HIV vaccine.

By Staff Reporter
#AIDS2016: ​HIV may be a prescribed benefit, but not all medical schemes cover ARVs
Article
/ 18 July 2016

#AIDS2016: ​HIV may be a prescribed benefit, but not all medical schemes cover ARVs

In theory medical aids fund ARVs, but in practice it’s a complex process, say doctors and activists.

By Laura Lopez Gonzalez
SA makes great strides in treating ‘strong’ TB
Article
/ 28 March 2016

SA makes great strides in treating ‘strong’ TB

The country has one of the highest tuberculosis burdens.
But it is rapidly gaining access to new diagnostic tools and medicine for drug-resistant TB.

By Staff Reporter
No image available
Article
/ 15 March 2016

Free ARVs are not enough: The hidden costs of treating HIV in Nigeria

Financial risk-protection mechanisms could alleviate the high food and transport costs incurred by rural people seeking to access treatment for HIV.

By Staff Reporter
SA registers a two-in-one pill that can prevent HIV infection
Article
/ 9 December 2015

SA registers a two-in-one pill that can prevent HIV infection

South Africa has become only the second country in the world to allow widespread access to groundbreaking HIV pre-exposure prophylaxis medication.

By Staff Reporter
Malawi ARVs traded on Jozi’s streets
Article
/ 4 December 2015

Malawi ARVs traded on Jozi’s streets

Health workers steal drugs that are bought by smugglers and sold to fearful "illegal" foreigners.

By Josephine Chinele and Bhekisisa Team
Malawi ARVs traded on Jozi’s streets
Article
/ 3 December 2015

Malawi ARVs traded on Jozi’s streets

Health workers steal drugs that are bought by smugglers and sold to fearful "illegal" foreigners.

By Josephine Chinele
Survey uncovers shortages in critical medication
Article
/ 10 June 2015

Survey uncovers shortages in critical medication

A survey of stock levels of HIV drugs is in stark contrast to health department claims that "there is no shortage".

By Mia Malan
Motsoaledi refutes claims SA faces drug shortages
Article
/ 25 May 2015

Motsoaledi refutes claims SA faces drug shortages

The health minister says the media portrays the department as failing to provide drugs for patients, but supply is also subject to business decisions.

By Bhekisisa Team
No image available
Article
/ 24 February 2015

Vaginal gel won’t protect women against HIV

The search for an anti-HIV microbicide continues, after a new trial has refuted the results of a previous study that found one to be effective.

By Staff Reporter
Was Mbeki pressured into watering down his Sona criticism?
Article
/ 16 February 2015

Was Mbeki pressured into watering down his Sona criticism?

Former president Thabo Mbeki may have backtracked on his Sona comments, but SA needs more credible leaders to lead the charge, says Verashni Pillay.

By Verashni Pillay
No image available
Article
/ 6 August 2014

New breast-feeding policy for HIV moms pays off

Exclusive breast-feeding, introduced in line with WHO guidelines, has proven safe for babies if the mother is on antiretroviral treatment.

By Ina Skosana
Motsoaledi reveals ‘progressive’ HIV treatment plans
Article
/ 24 July 2014

Motsoaledi reveals ‘progressive’ HIV treatment plans

New treatment schedules for pregnant women and other patients are set to bring South Africa in line with the World Health Organisation’s guidelines.

By Amy Green, Ina Skosana and Bhekisisa Team
Striking Amcu miners fall behind on ARV treatment
Article
/ 14 April 2014

Striking Amcu miners fall behind on ARV treatment

In a letter explaining benefits the company offers miners, Lonmin says striking Amcu members are falling behind on their antiretroviral treatments.

By Sapa and Staff Reporter
No image available
Article
/ 2 April 2014

Can we end Aids in Africa?

While much has been done to end Aids in Africa, more work by governments is necessary to move forward, particularly in SA.

By Staff Reporter
HIV research on monkeys makes breakthrough
Article
/ 5 March 2014

HIV research on monkeys makes breakthrough

A single shot of antiretroviral drugs has protected lab monkeys from HIV for weeks, according to two US trials.

By Bhekisisa Team
New HIV infections in SA fall by a third since 2004
Article
/ 17 January 2014

New HIV infections in SA fall by a third since 2004

Between 2004 and 2012, the number of new HIV infections have decreased from an estimated 540 000 to 370 000, shows a UNAids report.

By Sapa and Bhekisisa Team
No image available
Article
/ 2 January 2014

Relapse of ‘cured’ HIV patients spurs on Aids research

Two HIV positive patients, believed to have been cured, have tested positive again but scientists say they are inspired to continue research.

By Reuters
Shift in mood towards HIV
Article
/ 11 December 2013

Shift in mood towards HIV

A recent Cape Town AIDS conference showed a shift in the global mood on HIV.

By Mara Kardas-Nelson
No image available
Article
/ 3 December 2013

How true are reports of breakthrough Aids ‘cures’?

As the world recently marked World Aids Day, Africa Check has investigated the evidence behind three claims of an Aids breakthrough "cure".

By Staff Reporter
Prudence Mabele: “I have seen ARVs save lives”
Article
/ 29 November 2013

Prudence Mabele: “I have seen ARVs save lives”

Mabele helped lead the fight for antiretrovirals in SA. A memorial service will be held for her today. This was her last interview with Bhekisisa.

By Ina Skosana
Why has Gauteng run out of ARVs?
Article
/ 5 April 2013

Why has Gauteng run out of ARVs?

Patients go without key drugs as the province and suppliers trade blame for antiretroviral shortages.

By Staff Reporter
Daily ARV dose ineffective among Africa’s HIV-negative women
Article
/ 4 March 2013

Daily ARV dose ineffective among Africa’s HIV-negative women

According to HIV prevention trial results, the daily use of pills or a vaginal gel does not appear to prevent HIV-infection in African women.

By Mia Malan
Drop in infections follows ARVs’ success
Article
/ 21 February 2013

Drop in infections follows ARVs’ success

ARVs have slowed down the rate of new HIV infections and increased the life expectancy of the general population in rural KZN

By Staff Reporter
Clash over HIV drug’s ‘success’
Article
/ 17 August 2012

Clash over HIV drug’s ‘success’

Pressure’s mounting on SA’s Medicines Control Council to register the use of Truvada by the HIV-negative to lower chances of being infected with HIV.

By Mia Malan
← Older posts

MAIL & GUARDIAN

ABOUT

About
Contact
Advertise

SUBSCRIPTIONS

Subscribe
Newsletters

FOLLOW

WhatsApp Channel
Twitter
Facebook
YouTube
Instagram
LinkedIn
TikTok
Threads

FLAGSHIP EVENTS

200 Young South Africans
Power Of Women
Greening The Future

LEGAL & CORRECTIONS

Privacy Policy
Cookie Policy
Ethics & Social Media Policy

RESOURCES

Mail & Guardian Careers
Property for sale


Mail & Guardian

© 2025 The Mail & Guardian. All rights reserved.

  • Login
  • Register
Forgot Password?
Lost your password? Please enter your username or email address. You will receive a link to create a new password via email.
body::-webkit-scrollbar { width: 7px; } body::-webkit-scrollbar-track { border-radius: 10px; background: #f0f0f0; } body::-webkit-scrollbar-thumb { border-radius: 50px; background: #dfdbdb }